During the last session, AquaBounty Technologies Inc. (NASDAQ:AQB)’s traded shares were 0.65 million, with the beta value of the company hitting 1.08. At the end of the trading day, the stock’s price was $4.58, reflecting an intraday loss of -2.55% or -$0.12. The 52-week high for the AQB share is $13.32, that puts it down -190.83 from that peak though still a striking 39.52% gain since the share price plummeted to a 52-week low of $2.77. The company’s market capitalization is $313.41M, and the average intraday trading volume over the past 10 days was 0.57 million shares, and the average trade volume was 992.45K shares over the past three months.
AquaBounty Technologies Inc. (AQB) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 2.00. AQB has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.06.
AquaBounty Technologies Inc. (NASDAQ:AQB) trade information
AquaBounty Technologies Inc. (AQB) registered a -2.55% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.55% in intraday trading to $4.58 this Friday, 09/03/21, hitting a weekly high. The stock’s 5-day price performance is -1.29%, and it has moved by -6.53% in 30 days. Based on these gigs, the overall price performance for the year is 57.93%. The short interest in AquaBounty Technologies Inc. (NASDAQ:AQB) is 5.32 million shares and it means that shorts have 6.26 day(s) to cover.
The consensus price target of analysts on Wall Street is $11.00, which implies an increase of 58.36% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $7.00 and $15.00 respectively. As a result, AQB is trading at a discount of -227.51% off the target high and -52.84% off the low.
AquaBounty Technologies Inc. (AQB) estimates and forecasts
Statistics show that AquaBounty Technologies Inc. has outperformed its competitors in share price, compared to the industry in which it operates. AquaBounty Technologies Inc. (AQB) shares have gone down -28.16% during the last six months, with a year-to-date growth rate more than the industry average at 37.78% against 7.70. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to grow 45.50% this quarter and then jump 22.20% in the quarter after that. In the rating firms’ projections, revenue will increase 1,837.50% compared to the previous financial year.
Revenue for the current quarter is expected to be $227k as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to $680k by the end of Sep 2021.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 20.20%. While earnings are projected to return 31.50% in 2021.
AquaBounty Technologies Inc. is due to release its next quarterly earnings on March 09. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
AquaBounty Technologies Inc. (NASDAQ:AQB)’s Major holders
AquaBounty Technologies Inc. insiders own 1.26% of total outstanding shares while institutional holders control 56.31%, with the float percentage being 57.02%. Third Security, LLC is the largest shareholder of the company, while 122 institutions own stock in it. As of Jun 29, 2021, the company held over 18.22 million shares (or 25.65% of all shares), a total value of $97.66 million in shares.
The next largest institutional holding, with 6.84 million shares, is of ARK Investment Management, LLC’s that is approximately 9.63% of outstanding shares. At the market price on Jun 29, 2021, these shares were valued at $36.64 million.
Also, the Mutual Funds coming in first place with the largest holdings of AquaBounty Technologies Inc. (AQB) shares are ARK ETF Tr-ARK Genomic Revolution ETF and Vanguard Total Stock Market Index Fund. Data provided on Jun 29, 2021 indicates that ARK ETF Tr-ARK Genomic Revolution ETF owns about 6.84 million shares. This amounts to just over 9.63 percent of the company’s overall shares, with a $36.64 million market value. The same data shows that the other fund manager holds slightly less at 1.45 million, or about 2.04% of the stock, which is worth about $9.73 million.